STA
DPLO

Summit Trail Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Summit Trail Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,241
Closed -$31K – 1970
2017
Q4 		$31K Buy
+1,241
New +$24.4K ﹤0.01% 940

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Summit Trail Advisors's DPLO Position: Q1 2018 in Review

Summit Trail Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 1,241 shares — an estimated $31K sold.

Summit Trail Advisors first reported a position in DPLO in Q4 2017 and held it in 1 quarter. The position peaked at $31K in Q4 2017. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

  • Summit Trail Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 1,241 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $31K.
  • Summit Trail Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 1 quarter.
  • Summit Trail Advisors's DIPLOMAT PHARMACY, INC. position peaked at $31K in Q4 2017.
  • 201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.